COAG position history
The shares of Hemab Therapeutics (COAG) that Opaleye Management Inc. reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2026 Q2: 47,652 shares, $1.8M, 0.16% of portfolio, New
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|